Anemia has intense effects on the cardiovascular system. Many of these effects have said to be improved or reversed following erythropoietin therapy.
Tag: Heart disease in CKD
Adverse Effects of Erythropoietin Therapy in Dialysis Patients
Majority of the reported complications associated with erythropoietin therapy are not due to the recombinant product but due to the resultant increase in hematocrit and blood viscosity.
Heart Disease in Dialysis Patients
Although hemodialysis is a safe procedure for removing excess waste materials and fluid in kidney failure patients, the leading cause of death in dialysis patients is sudden heart attack.